# Integrated Quantitative Investments LLC

Type: Company

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/integrated-quantitative-investments-llc
Canonical HTML page: https://getfinancebrief.com/entity/integrated-quantitative-investments-llc

## Timeline

- **2026-03-15**: Eventide Rebalancing — Eventide Asset Management reports a reduced but significant stake of $83.65 million in Collegium.
- **2026-03-06**: Institutional Reduction — Integrated Quantitative Investments LLC reduces its stock position in COLL.
- **2026-02-18**: Truist Analysis — Truist Securities highlights momentum for Jornay PM and a robust pain portfolio.
- **2022-03-22**: BDSI Acquisition — Collegium completes the acquisition of BioDelivery Sciences International, adding Belbuca to its portfolio.

## Recent coverage (1 stories)

### Eventide Asset Management Trims Stake in Collegium Pharmaceutical to $83.6M
2026-03-15 12:47:55 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Eventide Asset Management LLC has reduced its equity position in Collegium Pharmaceutical, Inc. (COLL), though it maintains a significant $83.65 million stake. This institutional shift comes as the specialty pharmaceutical firm navigates a shifting landscape for chronic pain management and expands into neurology.
Full story: https://getfinancebrief.com/story/eventide-reduces-collegium-pharmaceutical-stake

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.